Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11029100 | Journal of Clinical Virology | 2018 | 5 Pages |
Abstract
There appears to be under-reporting and under-recognition of congenital CMV despite increasing use of antiviral therapy. Universal newborn CMV screening should be considered to facilitate follow-up of affected children and targeted linkage into hearing and developmental services, and to provide population-level infant CMV epidemiology to support research and evaluation of antiviral and adjunctive therapies.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Adam W. Bartlett, Beverley M. Hall, Pamela Palasanthiran, Brendan McMullan, Antonia W. Shand, William D. Rawlinson,